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Quality of Life 
Sir, 
I would like to make a number of comments regarding 
the paper by Pellet al. 1 Adequately controlled studies 
assessing quality of life, in patients with intermittent 
claudication using validated questionnaires, are cer- 
tainly lacking. Two previously published series have, 
however, looked at this - -  Hunt et al. 2 did not look 
specifically at claudicants and Arfvidsson et al. 3 
although they studied claudicants and linked quality 
of life with mobilit~ used historical data from a group 
of women as controls. 
The authors do not mention if the stopping distance 
was measured on a treadmill or obtained from the 
patient's history - -  patients are unreliable in this 
respect. Stopping distance is moreover a highly 
subjective measure and not an accurate indicator of 
disease severity. Furthermore, the definition of inter- 
mittent claudication does not mention a specific 
distance and by using a cut-off of 200m the authors are 
imposing a selection bias. 
The results of the SF-36 in this series are compared 
to normative data published 2years previously from a 
different population (Oxford) and of a different age 
group (18-64 years compared to the claudicants who 
are 36-87 years old). Does this really constitute a valid 
control group? 
The authors have not considered the impact of 
associated illnesses on quality of life in the claudi- 
cants. I have carried out a similar project using the 
Nottingham Health Profile (admittedly not as sensi- 
tive as the SF-36 for lesser degrees of disability) to 
assess quality of life in claudicants and a control 
group 4 and shown that additional disorders have a 
considerable impact on quality of life. 
It has been previously shown that there is disparity 
in patients' and clinicians' judgements of quality of 
life. 5"6 The results from Pe l le t  aI. support this 
conclusion, but it is interesting that patients tended to 
rate their quality of life higher than the surgeon. A 
recent leader by some of the surgeons involved in this 
paper stated that reconstructive surgery has not been 
widely applied to claudicants because the discomfort 
and restriction in lifestyle are not considered by 
clinicians to be severe enough to justify the surgical 
risks. 7 
Assessment of quality of life should be used in 
addition to morbidity and mortality in determining 
the outcome of various treatments. It may also help to 
justify the allocation of resources to various inter- 
ventions in claudicants - -  such as structured exercise 
programmes or percutaneous transluminal 
angioplasty. 
H. S. Khaira 
Sutton Coldfield, U.K. 
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Sir, 
As highlighted by Mr Khaira, previous tudies on the 
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effect of intermittent claudication on quality of life 
have included a heterogenous group of patients with a 
spectrum of diseases, or have failed to compare the 
results with an adequate control group. 
The stopping distance reported by the patient was 
used as a proxy measure of disease severity. Although 
not as accurate as treadmill measurement, i  is the 
measure used in dinical practice in the hospitals 
which participated in the stud)~ to determine which 
patients should be investigated further. Self-percep- 
tion of stopping distance may not correspond well to 
angiographic assessments of disease severit)~ but is 
the factor which determines the patient's perception of 
disease severit)~ and is the main parameter on which 
initial decisions are made on how aggressively to 
manage claudication. 
Mr Khaira is correct to point out that a control 
group should ideally be chosen from the same 
geographical area. However, SF36 data from the 
general population in Scotland was not available. In 
the absence of this data, comparison with data from 
Oxford is a reasonable alternative. Comorbidity can 
affect quality of life, and patients with intermittent 
claudication are more likely to suffer from diseases 
such as coronary and cerebrovascular disease than the 
general population. This study measured the overall 
quality of life of patients with claudication. Measure- 
ment and comparison of only that component of 
quality of life which is directly attributable to periph- 
eral arterial disease, would require development of 
validated disease-specific quality of life question- 
naires, or collection of comorbidity data in both the 
disease and control groups to allow for adjustment for 
the effects of such confounders. Information on 
comorbidity is not available for normative SF36 
data. 
We agree with the last comment of Mr Khaira that 
assessment and comparison of clinical outcomes 
should include consideration of quality of life. 
J. Pell on behalf of the Scottish Vascular Audit 
Group 
Glasgow, U.K. 
Quality of Life 
Sir, 
We have read with interest he article by Thompson et 
al. on quality of life following amputation or infra- 
genicular bypass. 1 Whilst acknowledging the impor- 
tance of quality of life studies, we feel the design of 
this study is sufficiently flawed to cast doubt on many 
of its conclusions. 
Retrospective analyses of quality of life are inevita- 
bly flawed when no attempt is made to evaluate the 
patient's quality of life prior to surgery. One cannot 
then be certain if the differences between groups 
represent the results of treatment, or merely represent 
a continuation of differences that existed prior to 
operation. Bias has also been introduced into the 
patient groups by favouring primary amputation for 
those patients with a premorbid inability to ambula- 
tion or severe dementia. 
The response rate to the postal questionnaire was 
reasonable at approximately 70%, but those failing to 
reply or those excluded from the study are likely to 
represent the most unhealth36 anxious and least well- 
motivated patients. Some patients have been assessed 
by questionnaire only 1 month after surgery. Those 
who have undergone amputation cannot be expected 
to have achieved any effective rehabilitation in this 
time, whereas the infragenicular bypass group may 
still be enjoying a "honeymoon period" following 
reconstructive surgery when the placebo effect of 
operation is still high. 
J. M. T. Perkins and T. S. O'Brien 
Oxford, U.K. 
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Sir, 
We thank Messrs Perkins and O'Brien for their 
comments. Whilst we acknowledge that retrospective 
studies are inferior to prospective analyses, we believe 
that continuing audit of results (from which our study 
was derived) is obligatory in modern surgical practice. 
Bias between the groups was undoubtedly introduced 
by differing therapeutic decisions, but we do not 
believe that limb salvage procedures are always 
appropriate in patients with a premorbid inability to 
ambulate. There is no evidence from our study that 
those patients who failed to return a questionnaire 
were the most anxious or less motivated patients. We 
regard the median follow up times in both groups of 
patients to be adequate in this type of stud)~ and 
would be interested to know the prospective trials that 
have demonstrated a placebo, "honeymoon period" 
on the quality of life following infragenicular 
bypass. 
M. M. Thompson and P. R. F. Bell 
Leicester, U.K. 
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